RBI
GILD icon

Raiffeisen Bank International’s Gilead Sciences GILD Stock Holding History

Raiffeisen Bank International’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Hold
1,028
– – ﹤0.01% 541
2026
Q1 		$143K Hold
1,028
– – ﹤0.01% 501
2025
Q4 		$106K Hold
1,028
– – ﹤0.01% 508
2025
Q3 		$114K Buy
+1,028
New +$117K ﹤0.01% 503

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Raiffeisen Bank International's GILD Position: Q2 2026 in Review

Raiffeisen Bank International increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $2.39M and bringing the position to 198,926 shares worth $25.1M. The position accounts for 0.29% of the portfolio, ranked #81.

Raiffeisen Bank International first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.4M in Q1 2025. 1,509 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Raiffeisen Bank International held 198,926 shares of Gilead Sciences worth $25.1M as of Q2 2026.
  • Raiffeisen Bank International bought 18,169 Gilead Sciences shares in Q2 2026, an estimated $2.39M.
  • Gilead Sciences made up 0.29% of Raiffeisen Bank International's portfolio in Q2 2026, its #81 holding.
  • Raiffeisen Bank International first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's Gilead Sciences position peaked at $26.4M in Q1 2025.
  • 1,509 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.